Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817492 · ClinicalTrials.gov registry record
Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 89
- Enrollment target
NCT00817492: Completed study, sponsored by University of Chicago.
NCT00817492 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00817492 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
This study will help determine the relationship between impaired sleep and chronic kidney disease, specifically to determine if sleep disturbances are a risk factor for worsening kidney function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2006-07 |
| Est. Completion | 2011-06 |
What the finished NCT00817492 record still lists
NCT00817492 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00817492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00817492 about?
NCT00817492 is a clinical study titled "Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois". This study will help determine the relationship between impaired sleep and chronic kidney disease, specifically to determine if sleep disturbances are a risk factor for worsening kidney function.
What is the current status of trial NCT00817492?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2006-07. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT00817492?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia